title: Supplementing Conventional Treatment with Pycnogenol® May Improve Hepatitis C Virus-Associated Type 2 Diabetes: A Mini Review.
abstract: Hepatitis C virus (HCV) infection and type 2 diabetes mellitus (T2DM) present a significant health burden, with increasing complications and mortality rates worldwide. Pycnogenol® (PYC), a natural product, possesses antidiabetic and antiviral properties that may improve HCV-associated T2DM. In this review, we present previously published data on the effectiveness of PYC against HCV replication and T2DM. We believe that supplementing conventional treatment with PYC may improve the current HCV therapy, attenuate HCV-associated T2DM, and reduce the risk of complications such as cirrhosis or hepatocellular carcinoma and cardiovascular disease.
authors: Virology Unit, Viral Hepatitis Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.
authors: Sayeh
authors: S
authors: Ezzikouri
authors: Virology Unit, Viral Hepatitis Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.
authors: Fatima Zahra
authors: FZ
authors: Jadid
authors: Virology Unit, Viral Hepatitis Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.
authors: Salsabil
authors: S
authors: Hamdi
authors: Virology Unit, Immunovirology Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.
authors: Lahcen
authors: L
authors: Wakrim
authors: Laboratory of Animal Hygiene, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan; Transboundary Animal Diseases Centre, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.
authors: Kyoko
authors: K
authors: Tsukiyama-Kohara
authors: Virology Unit, Viral Hepatitis Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.
authors: Soumaya
authors: S
authors: Benjelloun
keywords: Complementary medicine; Hepatitis C; Pycnogenol®; T2DM